Literature DB >> 29147726

[Radiculomyelopathy in schistosomiasis].

J Detzler1, H Backes2, J Guldner3.   

Abstract

The increasing migration of people from their homeland in far distant regions to Europe in the last few years has strongly influenced the rise of previously rarely seen diseases. They not only originate from the respective homeland but also from the transit countries during the migration process. We report the case of a 27-year-old male migrant from Eritrea, who after months of flight as a refugee travelling through various African countries, presented at our hospital with a progressive, painful radiculopathy. Whole spine magnetic resonance imaging (MRI) showed a focus located in the myelon, extending from T11 to the medullary conus. The differential diagnostic clarification ultimately revealed an infection with Schistosoma mansoni. After guideline-conform treatment with praziquantel for 3 days and additional administration of corticosteroids for 3 months, a slow regression of the findings and improvement of the symptoms could be shown clinically and by MRI. This case study shows the importance of taking the medical history and that a closer look at the potential exposure in the homeland and transit countries should be of great benefit in reaching the diagnosis, especially in patients with a migration background.

Entities:  

Keywords:  Antibodies; Differential blood count; Eosinophilia; Myelitis; Refugee

Mesh:

Substances:

Year:  2018        PMID: 29147726     DOI: 10.1007/s00115-017-0453-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  7 in total

1.  No overt cellular inflammation around intravascular schistosomes in vivo.

Authors:  John H Keating; R Alan Wilson; Patrick J Skelly
Journal:  J Parasitol       Date:  2006-12       Impact factor: 1.276

Review 2.  Involvement of central nervous system in the schistosomiasis.

Authors:  Teresa Cristina de Abreu Ferrari
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-10-13       Impact factor: 2.743

3.  High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees.

Authors:  Drew L Posey; Brian G Blackburn; Michelle Weinberg; Elaine W Flagg; Luis Ortega; Marianna Wilson; W Evan Secor; Kolby Sanders-Lewis; Kimberly Won; James H Maguire
Journal:  Clin Infect Dis       Date:  2007-10-11       Impact factor: 9.079

4.  Infectious Diseases in Sub-Saharan Immigrants to Spain.

Authors:  Núria Serre Delcor; Begoña Treviño Maruri; Antoni Soriano Arandes; Isabel Claveria Guiu; Hakima Ouaarab Essadik; Mateu Espasa Soley; Israel Molina Romero; Carlos Ascaso
Journal:  Am J Trop Med Hyg       Date:  2016-02-15       Impact factor: 2.345

5.  Praziquantel in treatment of cerebral schistosomiasis.

Authors:  G Watt; B Adapon; G W Long; M T Fernando; C P Ranoa; J H Cross
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

6.  The global status of schistosomiasis and its control.

Authors:  L Chitsulo; D Engels; A Montresor; L Savioli
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

7.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.